Logo

NIH to License Odyssey Thera for Molecular Libraries Roadmap Initiative

Aug 17, 2005

NEW YORK, Aug. 17 (GenomeWeb News) - Odyssey Thera will license its protein-fragment complementation assays to the National Institutes of Health to aid in the federal body's Molecular Libraries Roadmap Initiative, Odyssey said today.

The NIH will use the assays for screening small molecules with relevance to pharmaceutical discovery. According to the NIH, research using the technology will be conducted at the NIH's ChemicalGenomicsCenter.

Financial details were not disclosed.

Breaking News
The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.